LENZ THERAPEUTICS INC (LENZ) Stock Cash Flow
NASDAQ:LENZ - US52635N1037 - Common Stock
41.98 USD
+2.06 (+5.16%)
41 USD
-0.98 (-2.33%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -52.40M | -49.77M | -124.65M | -101.05M | -70.76M | |||
| Depreciation Amortization | 90.00K | 58.00K | 2.41M | 2.35M | 730.00K | |||
| Change In Working Capital | 578.00K | -13.09M | -39.22M | -7.21M | -2.50M | |||
| Other non cash items | 4.51M | 3.41M | 71.46M | 17.93M | 19.67M | |||
| OPERATING CASH FLOW | -47.22M | -59.39M | -90.01M | -87.98M | -52.85M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -685.00K | -468.00K | -10.86M | -6.59M | -5.74M | |||
| Other Investing Activity | -54.93M | -154.01M | 237.20M | -235.27M | N/A | |||
| INVESTING CASH FLOW | -55.61M | -154.48M | 226.35M | -241.86M | -5.74M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 56.42M | 83.55M | 257.00K | 680.00K | 417.47M | |||
| Other Financing Activity | -13.00K | 115.45M | -67.00K | -80.00K | N/A | |||
| FINANCING CASH FLOW | 56.40M | 199.00M | 190.00K | 600.00K | 417.47M | |||
| CHANGE IN CASH | -46.43M | -14.87M | 136.53M | -329.24M | 358.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -47.22M | -59.39M | -90.01M | -87.98M | -52.85M | |||
| Capital Expenditure | -685.00K | -468.00K | -10.86M | -6.59M | -5.74M | |||
| FREE CASH FLOW | -47.90M | -59.86M | -100.86M | -94.57M | -58.59M | |||
All data in USD